FDA Approved Continuous Glucose Monitors for Children and Adolescents

The FDA has approved several continuous glucose monitoring (CGM) systems for use in children and adolescents with diabetes as of July 2021. These systems provide valuable information for managing blood sugar levels and require medical supervision.

Here are some FDA-approved CGMs for children and adolescents:

1. 'Dexcom G6 Continuous Glucose Monitoring System': Suitable for children and adolescents aged 2 years and older with diabetes.

2. 'Medtronic MiniMed 670G System': Suitable for children and adolescents aged 7 years and older with type 1 diabetes.

3. 'Abbott FreeStyle Libre 2 System': Suitable for children and adolescents aged 4 years and older with diabetes.

It's crucial to consult with a healthcare professional for guidance and supervision on using these CGM systems.